Trump Administration May Exempt Some Pharma Products from Future Tariffs in Trade Policy Shift

pharmaceutical tariffs; tariff exemptions; Trump administration; Section 232 investigation; trade policy; reciprocal tariffs; generic pharmaceuticals; active pharmaceutical ingredients; commerce secretary authority